148 related articles for article (PubMed ID: 31555703)
1. The expression and clinical significance of serum IL-17 in patients with primary biliary cirrhosis.
Sun Q; Wang Q; Feng N; Meng Y; Li B; Luo D; Shang X; Lv J; Monsaf AM; Wang C; Ma X
Ann Transl Med; 2019 Aug; 7(16):389. PubMed ID: 31555703
[TBL] [Abstract][Full Text] [Related]
2. [Increased expression of IL-9 in peripheral blood and liver tissues of patients with primary biliary cirrhosis].
Wang Q; Luo D; Sun X; Feng N; Li H; Hu J; Yang W; Ma X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Dec; 32(12):1679-1682. PubMed ID: 27916102
[TBL] [Abstract][Full Text] [Related]
3. Increased IL-23 and IL-17 expression by peripheral blood cells of patients with primary biliary cirrhosis.
Qian C; Jiang T; Zhang W; Ren C; Wang Q; Qin Q; Chen J; Deng A; Zhong R
Cytokine; 2013 Oct; 64(1):172-80. PubMed ID: 23910013
[TBL] [Abstract][Full Text] [Related]
4. RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
Hao YL; Bian ZL; Ju LL; Liu Y; Qin G
Dig Dis Sci; 2020 Feb; 65(2):470-479. PubMed ID: 31377883
[TBL] [Abstract][Full Text] [Related]
5. Implication of increased serum stromal cell-derived factor-1 for primary biliary cholangitis.
Yang Z; Liang Y; Lin F; Zhang Z; Luo W; Zhang Y; Zhong R
Int Immunopharmacol; 2018 Mar; 56():285-290. PubMed ID: 29414663
[TBL] [Abstract][Full Text] [Related]
6. In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset.
Harada K; Van de Water J; Leung PS; Coppel RL; Ansari A; Nakanuma Y; Gershwin ME
Hepatology; 1997 Apr; 25(4):791-6. PubMed ID: 9096578
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 23 Produced by Hepatic Monocyte-Derived Macrophages Is Essential for the Development of Murine Primary Biliary Cholangitis.
Reuveni D; Brezis MR; Brazowski E; Vinestock P; Leung PSC; Thakker P; Gershwin ME; Zigmond E
Front Immunol; 2021; 12():718841. PubMed ID: 34484224
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-17A-Induced Epithelial-Mesenchymal Transition of Human Intrahepatic Biliary Epithelial Cells: Implications for Primary Biliary Cirrhosis.
Huang Q; Chu S; Yin X; Yu X; Kang C; Li X; Qiu Y
Tohoku J Exp Med; 2016 Dec; 240(4):269-275. PubMed ID: 27916760
[TBL] [Abstract][Full Text] [Related]
9. Lower Plasma Levels of IL-35 in Patients with Primary Biliary Cirrhosis.
Li T; Huang Y; Liu P; Liu Y; Guo J; Zhang W; Gu M; Qian C; Deng A
Tohoku J Exp Med; 2018 Feb; 244(2):123-131. PubMed ID: 29445068
[TBL] [Abstract][Full Text] [Related]
10. [Correlation study of estrogen receptor with peripheral blood cytokines and serum markers in primary biliary cirrhosis patients].
Wang L; Li QM; DU HH; Wang LQ; Liu YB; Zhang W
Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):336-9. PubMed ID: 22971276
[TBL] [Abstract][Full Text] [Related]
11. Cytokine mRNA expression in the liver of patients with primary biliary cirrhosis (PBC) and chronic hepatitis B (CHB).
Shindo M; Mullin GE; Braun-Elwert L; Bergasa NV; Jones EA; James SP
Clin Exp Immunol; 1996 Aug; 105(2):254-9. PubMed ID: 8706330
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of TIPE2 contributes to the hyperreactivity of monocyte to Toll-like receptor ligands in primary biliary cirrhosis.
Qin B; Wei T; Wang L; Ma N; Tang Q; Liang Y; Yang Z; Zhou L; Zhong R
J Gastroenterol Hepatol; 2016 Jun; 31(6):1177-83. PubMed ID: 26644386
[TBL] [Abstract][Full Text] [Related]
13. CXCL12-CXCR4-Mediated Chemotaxis Supports Accumulation of Mucosal-Associated Invariant T Cells Into the Liver of Patients With PBC.
Chen Z; Liu S; He C; Sun J; Wang L; Chen H; Zhang F
Front Immunol; 2021; 12():578548. PubMed ID: 33815355
[No Abstract] [Full Text] [Related]
14. Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis.
Zhao J; Zhao S; Zhou G; Liang L; Guo X; Mao P; Zhou X; Wang H; Nan Y; Xu D; Yu J
Scand J Gastroenterol; 2011 Apr; 46(4):485-94. PubMed ID: 21275501
[TBL] [Abstract][Full Text] [Related]
15. [Expression and clinical significance of interleukin-16 in patients with primary biliary cholangitis].
Liu QY; Li Y; Ma X; Tang RQ
Zhonghua Gan Zang Bing Za Zhi; 2021 Jun; 29(6):527-532. PubMed ID: 34225426
[No Abstract] [Full Text] [Related]
16. Implication of Increased Serum IL-31 for Primary Biliary Cholangitis.
Mu N; Lin F; Jiang Z; Liang Y; Yang Z
Immunol Invest; 2021 Aug; 50(6):662-670. PubMed ID: 32613870
[TBL] [Abstract][Full Text] [Related]
17. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy.
Yang CY; Ma X; Tsuneyama K; Huang S; Takahashi T; Chalasani NP; Bowlus CL; Yang GX; Leung PS; Ansari AA; Wu L; Coppel RL; Gershwin ME
Hepatology; 2014 May; 59(5):1944-53. PubMed ID: 24375552
[TBL] [Abstract][Full Text] [Related]
18. TNFSF9 expression in primary biliary cirrhosis and its clinical significance.
Xia R; Tang Y; Huang Y; Yao D; Zhou Y; Chen B; Chen Y; Chen S; Deng A; Zhong R
Cytokine; 2010 Jun; 50(3):311-6. PubMed ID: 20303781
[TBL] [Abstract][Full Text] [Related]
19. [Abnormal expression of miR-let-7b in primary biliary cirrhosis and its clinical significance].
Qian C; Chen SX; Ren CL; Zhong RQ; Deng AM; Qin Q
Zhonghua Gan Zang Bing Za Zhi; 2013 Jul; 21(7):533-6. PubMed ID: 24074714
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of alkaline phosphatase (ALP) in the liver of primary biliary cirrhosis (PBC) patients.
Suzuki N; Irie M; Iwata K; Nakane H; Yoshikane M; Koyama Y; Uehara Y; Takeyama Y; Kitamura Y; Sohda T; Watanabe H; Ikehara Y; Sakisaka S
Hepatol Res; 2006 May; 35(1):37-44. PubMed ID: 16567122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
